av/cymabay-therapeutics--big.svg

COM:CYMABAY

CymaBay Therapeutics Inc

  • Stock

USD

Last Close

32.47

21/03 20:00

Market Cap

3.73B

Beta: -

Volume Today

8.35M

Avg: -

Company Overview

Metric
Company NameCymaBay Therapeutics, Inc.
SymbolCBAY
MSH IDCOM:CYMABAY
MarketSTOCKS
SectorHealthcare
IndustryBiotechnology
CountryUS
Stage
Employee Count101
Websitecymabay.com
LinkedIncymabay-therapeutics
Founders

Market Metrics

Metric
Market Cap3.73B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue31.07M
Revenue (LTM)
Revenue (NTM)
Gross Profit30.39M
EBITDA-101.00M
Operating Income-101.68M
Net Income-105.37M
EPS-0.99
Diluted EPS-0.99
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.98
Operating Profit Margin-3.27
EBITDA Margin-3.25
Net Profit Margin-3.59
Return on Equity-0.54
Return on Assets-0.26
Return on Capital Employed-0.26

Valuation Multiples

Metric
P/E Ratio-23.78
P/B Ratio7.74
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio119.98
EV Multiple-40.30

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle-2.05K
Asset Turnover0.07

Cash Flow Metrics

Metric
Operating Cash Flow-72.53M
Free Cash Flow-72.98M
Cash Flow to Debt-0.66
Operating Cash Flow/Sales-2.33
Free Cash Flow Yield-0.02

Balance Sheet Metrics

Metric
Cash & Equivalents206.53M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization0.27
Debt to Assets0.23
Current Ratio22.76
Quick Ratio10.70

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.42
R&D to Revenue2.39
SG&A to Revenue1.27